FDA Issues Warning for SGLT2 Inhibitor Use
The FDA has received 20 reports of forms of ketoacidosis in patients treated with SGLT2 inhibitors from March 2013 to June 2014 which resulted in either emergency room visits or hospitalization. There is an ongoing investigation of the safety issue related to this class of drugs.
If you experienced complications after using a SGLT2 inhibitor to treat your diabetes, you may be entitled to compensation.
Drug brands linked to serious health risks include:
- Xigduo XR®
We work to help protect your rights and fight to get you the FINANCIAL COMPENSATION you deserve! Qualifying is 100% FREE. There is ZERO OBLIGATION - simply speak to one of our expert lawyers for your FREE legal case review! Unless you win your case & receive a settlement, you pay NO LEGAL FEES!